Amivas US LLC

Amivas US LLC is a limited liability company based in the United States. The company is a joint venture between Australian, Canadian, and United States entities, employing four people. Amivas US LLC specializes in the development, manufacturing, and commercialization of therapeutics for the treatment of infectious diseases. Their focus is on providing critical medications, exemplified by their FDA-approved Artesunate for Injection, a treatment for severe malaria. Driven by a mission to combat infectious diseases, Amivas US LLC stepped in to address the discontinuation of quinidine gluconate, a previous treatment for severe malaria. Their commitment to filling this crucial gap in medication access highlights their dedication to global health initiatives. For inquiries regarding Amivas US LLC and their products, interested parties can visit their website at amivas.com or consult their latest press release.